Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

An integrative analysis of consortium-based multi-omics QTL and genome-wide association study data uncovers new biomarkers for lung cancer

Yanru Wang, Aoxuan Wang, Ning Xie, Xiaowen Xu, Xiang Wang, Mengshen Zhao, Xuan Wang, Jiacheng Zhou, Yang Zhao, Zhibin Hu, Hongbing Shen, View ORCID ProfileRayjean J. Hung, View ORCID ProfileChristopher I. Amos, Yi Li, David C. Christiani, Feng Chen, Yongyue Wei, View ORCID ProfileRuyang Zhang
doi: https://doi.org/10.1101/2024.12.13.24318992
Yanru Wang
1Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aoxuan Wang
1Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ning Xie
1Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaowen Xu
1Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiang Wang
1Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mengshen Zhao
1Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuan Wang
1Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiacheng Zhou
1Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yang Zhao
1Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
2China International Cooperation Center (CICC) for Environment and Human Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhibin Hu
2China International Cooperation Center (CICC) for Environment and Human Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
3Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
4Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China
5State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongbing Shen
2China International Cooperation Center (CICC) for Environment and Human Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
3Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
4Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rayjean J. Hung
6Lunenfeld-Tanenbaum Research Institute, Sinai Health, and University of Toronto, Toronto, ON, Canada M5G 1X5
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rayjean J. Hung
Christopher I. Amos
7The Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX 77030, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher I. Amos
Yi Li
8Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David C. Christiani
9Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
10Pulmonary and Critical Care Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feng Chen
1Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
2China International Cooperation Center (CICC) for Environment and Human Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
4Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, Jiangsu 211166, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zhangruyang{at}njmu.edu.cn ywei{at}pku.edu.cn fengchen{at}njmu.edu.cn
Yongyue Wei
11Center for Public Health and Epidemic Preparedness & Response, Peking University, Beijing, 100191, China
12Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, 100191, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zhangruyang{at}njmu.edu.cn ywei{at}pku.edu.cn fengchen{at}njmu.edu.cn
Ruyang Zhang
1Department of Biostatistics, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
2China International Cooperation Center (CICC) for Environment and Human Health, Nanjing Medical University, Nanjing, Jiangsu 211166, China
13Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu 213164, China
14Information Center, The Affiliated Changzhou Second People’s Hospital of Nanjing Medical University, Changzhou, Jiangsu 213164, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ruyang Zhang
  • For correspondence: zhangruyang{at}njmu.edu.cn ywei{at}pku.edu.cn fengchen{at}njmu.edu.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

The role of molecular traits (e.g., gene expression and protein abundance) in the occurrence, development, and prognosis of lung cancer has been extensively studied. However, biomarkers in other molecular layers and connections among various molecular traits that influence lung cancer risk remain largely underexplored. We conducted the first comprehensive assessment of the associations between molecular biomarkers (i.e., DNA methylation, gene expression, protein and metabolite) and lung cancer risk through epigenome-wide association study (EWAS), transcriptome-wide association study (TWAS), proteome-wide association study (PWAS) and metabolome-wide association study (MWAS), and then we synthesized all omics layers to reveal potential regulatory mechanisms across layers. Our analysis identified 61 CpG sites, 62 genes, 6 proteins, and 5 metabolites, yielding 123 novel biomarkers. These biomarkers highlighted 90 relevant genes for lung cancer, 83 among them were first established in our study. Multi-omics integrative analysis revealed 12 of these genes overlapped across omics layers, suggesting cross-omics interactions. Moreover, we identified 106 potential cross-layer regulatory pathways, indicating that cell proliferation, differentiation, immunity, and protein-catalyzed metabolite reaction interact to influence lung cancer risk. Further subgroup analyses revealed that biomarker distributions differ across patient subgroups. To share all signals in different omics layers with community, we released a free online platform, LungCancer-xWAS, which can be accessed at http://bigdata.njmu.edu.cn/LungCancer-xWAS/. Our findings underscore the importance of xWAS which integrating various types of molecular quantitative trait loci (xQTL) data with genome-wide association study (GWAS) data to deepen understanding of lung cancer pathophysiology, which may provide valuable insights into potential therapeutic targets for the disease.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding: This study was funded by the National Natural Science Foundation of China (81530088 to F.C., 82273737 to R.Z., 82373690 to Y.Z., and 81973142 to Y.W.), US National Institutes of Health (CA209414, HL060710 and ES000002 to D.C.C.) and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). R.Z. was partially supported by the Qing Lan Project of the Higher Education Institutions of Jiangsu Province and the Outstanding Young Level Academic Leadership Training Program of Nanjing Medical University. *Correspondence: Ruyang Zhang (zhangruyang{at}njmu.edu.cn); Feng Chen (fengchen{at}njmu.edu.cn); Yang Zhao (zhaoyang{at}njmu.edu.cn); Yongyue Wei (ywei{at}pku.edu.cn); David C Christiani (dchris{at}hsph.harvard.edu).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics committee of Nanjing Medical University gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • ↵§ D.C.C., Y.L., C.I.A., R.J.H., H.S. and Z.H. are senior authors who supervise the work.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted December 16, 2024.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
An integrative analysis of consortium-based multi-omics QTL and genome-wide association study data uncovers new biomarkers for lung cancer
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
An integrative analysis of consortium-based multi-omics QTL and genome-wide association study data uncovers new biomarkers for lung cancer
Yanru Wang, Aoxuan Wang, Ning Xie, Xiaowen Xu, Xiang Wang, Mengshen Zhao, Xuan Wang, Jiacheng Zhou, Yang Zhao, Zhibin Hu, Hongbing Shen, Rayjean J. Hung, Christopher I. Amos, Yi Li, David C. Christiani, Feng Chen, Yongyue Wei, Ruyang Zhang
medRxiv 2024.12.13.24318992; doi: https://doi.org/10.1101/2024.12.13.24318992
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
An integrative analysis of consortium-based multi-omics QTL and genome-wide association study data uncovers new biomarkers for lung cancer
Yanru Wang, Aoxuan Wang, Ning Xie, Xiaowen Xu, Xiang Wang, Mengshen Zhao, Xuan Wang, Jiacheng Zhou, Yang Zhao, Zhibin Hu, Hongbing Shen, Rayjean J. Hung, Christopher I. Amos, Yi Li, David C. Christiani, Feng Chen, Yongyue Wei, Ruyang Zhang
medRxiv 2024.12.13.24318992; doi: https://doi.org/10.1101/2024.12.13.24318992

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3281)
  • Dentistry and Oral Medicine (362)
  • Dermatology (274)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1164)
  • Epidemiology (13340)
  • Forensic Medicine (19)
  • Gastroenterology (897)
  • Genetic and Genomic Medicine (5131)
  • Geriatric Medicine (479)
  • Health Economics (781)
  • Health Informatics (3253)
  • Health Policy (1138)
  • Health Systems and Quality Improvement (1189)
  • Hematology (427)
  • HIV/AIDS (1014)
  • Infectious Diseases (except HIV/AIDS) (14613)
  • Intensive Care and Critical Care Medicine (910)
  • Medical Education (475)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4901)
  • Nursing (261)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2516)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (346)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (540)
  • Pediatrics (1298)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4193)
  • Public and Global Health (7482)
  • Radiology and Imaging (1702)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (478)
  • Sexual and Reproductive Health (495)
  • Sports Medicine (424)
  • Surgery (546)
  • Toxicology (71)
  • Transplantation (235)
  • Urology (203)